Insider Kevin Norrett plans CDXS (NASDAQ: CDXS) share sale

Rhea-AI Filing Summary

An affiliate of the issuer filed a notice of proposed sale of 3,291 shares of common stock, with an aggregate market value of $4,179.57. The shares are expected to be sold on 02/06/2026 on the NASDAQ through Morgan Stanley Smith Barney Executive Financial Services.

These shares were acquired on 02/06/2026 via RSU vesting and settlement from the issuer as consideration for services rendered. In the preceding three months, Kevin Norrett sold 6,123 shares for $10,389.80 on 01/07/2026 and 1,745 shares for $2,914.32 on 01/16/2026.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney Executive Financial Services 1 New York Plaza, 8th Floor New York NY 10004	3291	4179.57	90324383	02/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/06/2026	RSU vesting and settlement	Issuer			3291	02/06/2026	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kevin Norrett 200 Penobscot Drive Redwood Citu CA 94063	Common Stock	01/07/2026	6123	10389.80
Kevin Norrett 200 Penobscot Drive Redwood City CA 94063	Common Stock	01/16/2026	1745	2914.32

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing for CDXS disclose?

The filing discloses a planned sale of 3,291 shares of common stock, with an aggregate market value of $4,179.57, to be executed on NASDAQ through Morgan Stanley Smith Barney Executive Financial Services on February 6, 2026, under Rule 144 resale provisions.

How many CDXS shares are planned to be sold and at what value?

The notice covers a proposed sale of 3,291 shares of common stock with an aggregate market value of $4,179.57. These figures reflect the amount the filer expects to sell and the corresponding market value at the time of the notice.

How were the CDXS shares in this Form 144 acquired?

The 3,291 shares were acquired on February 6, 2026 through RSU vesting and settlement from the issuer. The consideration listed is services rendered, meaning the shares represent equity compensation rather than a cash purchase by the reporting person.

What prior CDXS share sales by Kevin Norrett are reported?

The filing lists two recent sales by Kevin Norrett: 6,123 common shares sold on January 7, 2026 for gross proceeds of $10,389.80, and 1,745 common shares sold on January 16, 2026 for gross proceeds of $2,914.32, both reported for aggregation purposes.

Which broker and exchange are involved in the planned CDXS share sale?

The proposed sale will be executed through Morgan Stanley Smith Barney Executive Financial Services, located at 1 New York Plaza, New York. The shares are planned to be sold on the NASDAQ exchange, as specified in the Form 144 securities information section.

What representation does the seller make in this CDXS Form 144?

By signing the notice, the seller represents they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144 and related representations referenced in the form’s signature section.